HC Wainwright & Co. Maintains Buy on Rockwell Medical, Lowers Price Target to $2

HC Wainwright & Co. analyst Raghuram Selvaraju has maintained a Buy rating on Rockwell Medical (NASDAQ: RMTI) but has lowered the price target from $2.50 to $2.